38927649|t|PON1, APOE and SDF-1 Gene Polymorphisms and Risk of Retinal Vein Occlusion: A Case-Control Study.
38927649|a|Numerous studies have tried to evaluate the potential role of thrombophilia-related genes in retinal vein occlusion (RVO); however, there is limited research on genes related to different pathophysiological mechanisms involved in RVO. In view of the strong contribution of oxidative stress and inflammation to the pathogenesis of RVO, the purpose of the present study was to investigate the association of inflammation- and oxidative-stress-related polymorphisms from three different genes [apolipoprotein E (APOE), paraoxonase 1 (PON1) and stromal cell-derived factor 1 (SDF-1)] and the risk of RVO in a Greek population. Participants in this case-control study were 50 RVO patients (RVO group) and 50 healthy volunteers (control group). Blood samples were collected on EDTA tubes and genomic DNA was extracted. Genotyping of rs854560 (L55M) and rs662 (Q192R) for the PON1 gene, rs429358 and rs7412 for the APOE gene and rs1801157 [SDF1-3'G(801)A] for SDF-1 gene was performed using the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. Multiple genetic models (codominant, dominant, recessive, overdominant and log-additive) and haplotype analyses were performed using the SNPStats web tool to assess the correlation between the genetic polymorphisms and the risk of RVO. Binary logistic regression analysis was used for the association analysis between APOE gene variants and RVO. Given the multifactorial nature of the disease, our statistical analysis was adjusted for the most important systemic risk factors (age, hypertension and diabetes mellitus). The dominant genetic model for the PON1 Q192R single nucleotide polymorphism (SNP) of the association analysis revealed that there was a statistically significant difference between the RVO group and the control group. Specifically, after adjusting for age and hypertension, the PON1 192 R allele (QR + RR) was found to be associated with a statistically significantly higher risk of RVO compared to the QQ genotype (OR = 2.51; 95% CI = 1.02-6.14, p = 0.04). The statistically significant results were maintained after including diabetes in the multivariate model in addition to age and hypertension (OR = 2.83; 95% CI = 1.01-7.97, p = 0.042). No statistically significant association was revealed between the other studied polymorphisms and the risk of RVO. Haplotype analysis for PON1 SNPs, L55M and Q192R, revealed no statistically significant correlation. In conclusion, PON1 192 R allele carriers (QR + RR) were associated with a statistically significantly increased risk of RVO compared to the QQ homozygotes. These findings suggest that the R allele of the PON1 Q192R is likely to play a role as a risk factor for retinal vein occlusion.
38927649	0	4	PON1	Gene	5444
38927649	6	10	APOE	Gene	348
38927649	15	20	SDF-1	Gene	6387
38927649	52	74	Retinal Vein Occlusion	Disease	MESH:D012170
38927649	160	173	thrombophilia	Disease	MESH:D019851
38927649	191	213	retinal vein occlusion	Disease	MESH:D012170
38927649	215	218	RVO	Disease	MESH:D012170
38927649	328	331	RVO	Disease	MESH:D012170
38927649	392	404	inflammation	Disease	MESH:D007249
38927649	428	431	RVO	Disease	MESH:D012170
38927649	504	516	inflammation	Disease	MESH:D007249
38927649	589	605	apolipoprotein E	Gene	348
38927649	607	611	APOE	Gene	348
38927649	614	627	paraoxonase 1	Gene	5444
38927649	629	633	PON1	Gene	5444
38927649	639	668	stromal cell-derived factor 1	Gene	6387
38927649	670	675	SDF-1	Gene	6387
38927649	694	697	RVO	Disease	MESH:D012170
38927649	769	772	RVO	Disease	MESH:D012170
38927649	773	781	patients	Species	9606
38927649	783	786	RVO	Disease	MESH:D012170
38927649	869	873	EDTA	Chemical	MESH:D004492
38927649	925	933	rs854560	SNP	tmVar:rs854560;VariantGroup:1;CorrespondingGene:5444;RS#:854560;CorrespondingSpecies:9606
38927649	935	939	L55M	ProteinMutation	tmVar:p|SUB|L|55|M;HGVS:p.L55M;VariantGroup:1;CorrespondingGene:5444;RS#:854560;CorrespondingSpecies:9606;CA#:123413
38927649	945	950	rs662	SNP	tmVar:rs662;VariantGroup:0;CorrespondingGene:5444;RS#:662;CorrespondingSpecies:9606
38927649	952	957	Q192R	ProteinMutation	tmVar:p|SUB|Q|192|R;HGVS:p.Q192R;VariantGroup:0;CorrespondingGene:5444;RS#:662;CorrespondingSpecies:9606;CA#:123411
38927649	967	971	PON1	Gene	5444
38927649	978	986	rs429358	SNP	tmVar:rs429358;VariantGroup:3;CorrespondingGene:348;RS#:429358;CorrespondingSpecies:9606
38927649	991	997	rs7412	SNP	tmVar:rs7412;VariantGroup:2;CorrespondingGene:348;RS#:7412;CorrespondingSpecies:9606
38927649	1006	1010	APOE	Gene	348
38927649	1020	1029	rs1801157	SNP	tmVar:rs1801157;VariantGroup:4;CorrespondingGene:6387;RS#:1801157;CorrespondingSpecies:9606
38927649	1031	1035	SDF1	Gene	6387
38927649	1038	1045	G(801)A	DNAMutation	tmVar:c|SUB|G|801|A;HGVS:c.801G>A;VariantGroup:4;CorrespondingGene:6387;RS#:1801157;CorrespondingSpecies:9606;CA#:15646964
38927649	1051	1056	SDF-1	Gene	6387
38927649	1403	1406	RVO	Disease	MESH:D012170
38927649	1490	1494	APOE	Gene	348
38927649	1513	1516	RVO	Disease	MESH:D012170
38927649	1655	1667	hypertension	Disease	MESH:D006973
38927649	1672	1689	diabetes mellitus	Disease	MESH:D003920
38927649	1727	1731	PON1	Gene	5444
38927649	1732	1737	Q192R	ProteinMutation	tmVar:p|SUB|Q|192|R;HGVS:p.Q192R;VariantGroup:0;CorrespondingGene:5444;RS#:662;CorrespondingSpecies:9606;CA#:123411
38927649	1878	1881	RVO	Disease	MESH:D012170
38927649	1953	1965	hypertension	Disease	MESH:D006973
38927649	1971	1975	PON1	Gene	5444
38927649	1976	1981	192 R	ProteinMutation	tmVar:p|Allele|R|192;VariantGroup:0;CorrespondingGene:5444;RS#:662;CorrespondingSpecies:9606
38927649	2076	2079	RVO	Disease	MESH:D012170
38927649	2221	2229	diabetes	Disease	MESH:D003920
38927649	2279	2291	hypertension	Disease	MESH:D006973
38927649	2446	2449	RVO	Disease	MESH:D012170
38927649	2474	2478	PON1	Gene	5444
38927649	2485	2489	L55M	ProteinMutation	tmVar:p|SUB|L|55|M;HGVS:p.L55M;VariantGroup:1;CorrespondingGene:5444;RS#:854560;CorrespondingSpecies:9606;CA#:123413
38927649	2494	2499	Q192R	ProteinMutation	tmVar:p|SUB|Q|192|R;HGVS:p.Q192R;VariantGroup:0;CorrespondingGene:5444;RS#:662;CorrespondingSpecies:9606;CA#:123411
38927649	2567	2571	PON1	Gene	5444
38927649	2572	2577	192 R	ProteinMutation	tmVar:p|Allele|R|192;VariantGroup:0;CorrespondingGene:5444;RS#:662;CorrespondingSpecies:9606
38927649	2673	2676	RVO	Disease	MESH:D012170
38927649	2757	2761	PON1	Gene	5444
38927649	2762	2767	Q192R	ProteinMutation	tmVar:p|SUB|Q|192|R;HGVS:p.Q192R;VariantGroup:0;CorrespondingGene:5444;RS#:662;CorrespondingSpecies:9606;CA#:123411
38927649	2814	2836	retinal vein occlusion	Disease	MESH:D012170
38927649	Positive_Correlation	MESH:D012170	RS#:662;CorrespondingGene:5444
38927649	Association	MESH:D006973	5444
38927649	Association	MESH:D012170	6387
38927649	Positive_Correlation	MESH:D012170	RS#:854560;CorrespondingGene:5444
38927649	Positive_Correlation	MESH:D012170	RS#:429358;CorrespondingGene:348
38927649	Association	MESH:D012170	348
38927649	Positive_Correlation	MESH:D012170	RS#:854560;CorrespondingGene:5444
38927649	Positive_Correlation	MESH:D012170	RS#:662;CorrespondingGene:5444
38927649	Positive_Correlation	MESH:D012170	RS#:662;HGVS:p.Q192R;CorrespondingGene:5444
38927649	Association	MESH:D012170	5444

